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Efﬁcacy of Antibiotic-Impregnated Bone Cement
Beads Against Organisms Found in Abdominal
Vascular Graft Infections
Fernando Kubrusly, Samuel S. Leake, Harleen K. Sandhu,
Ali Azizzadeh, Hazim J. Saﬁ, Kristofer M. Charlton-Ouw.
Department of Cardiothoracic and Vascular Surgery,
University of Texas at Houston Medical School,
Houston, Tex
Objectives: Graft infection often involves several
different organisms. Antibiotic-impregnated polymethyl-
methacrylate (PMMA) beads may be effective in control-
ling reinfection after infected graft replacement. We
sought to determine an effective antibiotic combination
in PMMA beads for use in vascular graft infection.
Methods: PMMA beads were impregnated with
different combinations of antibiotics including daptomycin
(DA), tobramycin (TO), and meropenim (ME). Beads
were plated into separate 0.8% Mueller-Hinton agar plates
with vancomycin-resistent enterococcus (VRE), Klebsiella,
S. epidermidis, and methicillin-resistent Staphylococcus
aureus (MRSA). Antibiotic inhibition was recorded in
millimeters using the disc agar-diffusion method and aver-
aged from three separate platings.
Results: DA alone was not active against Klebsiella
(average ¼ 0 mm). TO alone was not active against
VRE, Klebsiella, or MRSA. ME showed broad-spectrum
activity against all organisms with >15 mm inhibition
halo. The efﬁcacy of ME was decreased by TO but
not DA. Adding DA and TO to ME did not improve
efﬁcacy.
Conclusions: Meropenem in PMMA beads shows
activity against difﬁcult pathogens encountered in vascular
graft infections. Daptomycin can be added for double-
coverage against multi-drug resistant gram-positive patho-
gens such as VRE and MRSA. Tobramycin appears
to reduce the efﬁcacy of meropenem when used in com-
bination.
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disclose.Table. Average inhibition halo in millimeters
VRE Klebsiella S. epidermidis MRSA
DA 9.8 0 10.2 9.6
TO 2.0 10.7 14.0 4.7
DA + TO 8.0 10.8 14.3 9.9
ME 17.0 15.3 21.0 17.3
ME + DA 17.2 16 21.7 17.7
ME + TO 13.8 13.5 16.7 13.4
ME + DA + TO 16.9 15.0 21.0 17.0
Control 3.2 6.9 8.7 4.2PS188.
Is Oxidative Stress Important in AAA Pathogenesis?
Sigitas Urbonavicius1, Grazina Urbonaviciene2, Jes
Sandermann1. 1Department of Vascular surgery,
Regionshospital Midt, Viborg, Denmark; 2Department of
Internal medicine, Regionshospital Midt, Silkeborg,
Denmark
Objectives: Active investigations continue to identify
markers other than size that would predict a risk of AAA
rupture. Circulating biomarkers could also indicate optimal
intervals between the surveillance intervals. Finally, the
identiﬁcation of biomarkers also may identify potential
pathogenic pathways, and thus may open possibilities for
pharmacological inhibition of growth. In the search of
novel biomarkers of AAA progression, serum and wall
material proteins were analyzed by a differential proteomic
approach.
Methods: Same layers of AAA wall from ruptured
(rAAA) and non-ruptured AAA were incubated, and
the proteins released were analyzed by 2-dimensional
difference in-gel electrophoresis. Proteins from serum
were analyzed and correlated with AAA annual expansion
rate.
Results: Several differentially expressed proteins
involved in main AAA pathological mechanisms (proteol-
ysis, oxidative stress, and thrombosis) were identiﬁed by
mass spectrometry. Among the proteins identiﬁed, peroxir-
edoxin-2 (PRX-2) was more permanent, which was further
validated by Western blot and immunohistochemistry. We
demonstrated increased PRX-2 serum levels in rAAA
patient wall material compared with AAA subjects and
also positive correlation in serum among PRX-2 and AAA
diameter and annual expansion rate. Finally, a prospective
study revealed a positive correlation between PRX-2 serum
levels and AAA expansion rate.
Conclusions: Several proteins associated with AAA
pathogenesis have been identiﬁed by a proteomic approach
Protein proﬁles identiﬁed in the serum would appear to be
a convenient monitoring tool that has the ability to be both
sensitive and speciﬁc for AAAs. PRX-2 serum levels are
increased in rAAA patients and correlate with AAA size
and growth rate, suggesting the potential use of PRX-2
as a biomarker for AAA evolution.
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Urine mRNA as an Early and Novel Marker of
Contrast-Induced Kidney Injury (CIKI)
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Objectives: CIKI is a common etiology of renal
dysfunction in hospitalized patients, and affects the daily
practice of vascular surgeons. It increases mortality, costs
and LOS; yet no direct or speciﬁc marker exists. Indirect
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into makers of early kidney injury has focused on various
proteins with disappointing results. Our animal data
revealed that even low dose contrast leads to kidney injury
and nephron-speciﬁc mRNA can be detected in the urine.
We wished to evaluate if nephron-speciﬁc mRNA could be
detected in patients after endovascular procedures as a new,
speciﬁc marker for CIKI.
Methods: Adults undergoing endovascular proce-
dures requiring contrast were consented. Urine was
collected over 24hrs. Urinalysis and mRNA extraction fol-
lowed. rtPCR using nephron-speciﬁc (Nephrin, Podocin,
Aquaporin-2) and a non-speciﬁc (TBF-Beta) probes. Clin-
ical data was also collected.
Results: Avg contrast:116cc. Avg age:69. Signiﬁcant
increases were found only in Nephrin mRNA at 6hrs,
and returned to baseline (n ¼ 20; P ¼ .03 - see graph).
Hematuria preceded this at 3hrs (P < .02) after contrast
exposure. There was no increase in the serum Cr (it
decreased).
Conclusions: Consistent with our animal model,
Nephrin mRNA and blood are detectable in the urine
within hours after contrast exposure, regardless of serum
creatinine. Urine mRNA is a potentially sensitive marker
for CIN.
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Nothing to disclose; D. Slack: Nothing to disclose.Fig. Nephrin mRNA detected in urine (normalized to urine
creatinine) prior to contrast exposure (time 0) or up to 24 hours
after ﬁrst contrast dose.
Fig. HIF-1a inhibition suppresses experimental AAA. Male
C57BL/6J mice were treated with vehicle, 2-ME (50 mg/kg/
day) or digoxin (2 mg/kg/day) starting 1 days prior to PRE
infusion, for a total of 15 days. Serial aortic diameter measurements
were performed using transabdominal ultrasonography. A, Fold
changes in mRNA expression in HiF-1a and VEGF-A, Rory-t,
Glut-1, and NOX2 in aneurysmal aortae (PRE infusion) and
control aortae (PBS infusion) as compared to normal mouse
aortae. B, Aortic diameter change following PPE infusion and
treatment with vehicle alone, 2ME or digoxin (chemical and
pharmaceutical grade) in vehicle. Data presented as mean plus
standard derivation. Two-way ANOVA followed by Newman-
Keuls test, *P < .05 and **P < .01 compared to vehicle treatment.
n ¼ 5-8 mice in each group.PS192.
Inhibition of Hypoxia Inducible Factor (HIF)-1a
Suppresses Formation and Progression of
Experimental Abdominal Aortic Aneurysms (AAAs)Wei Wang1, Baohui Xu1, Haojun Xuan1, Hiroki Tanaka1,
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of Medicine, Stanford, Calif; 2Pathology, Stanford
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Objectives: HIF-1a critically regulates angiogenesis,
a histopathological feature of AAA disease. This study eval-
uated whether 2-methyoxyestradiol (2-ME) or digoxin,
known HIF-1a inhibitors, modulate experimental AAAs.
Methods: AAAs were created in male C57BL/6J
mice via transient intra-aortic porcine pancreatic elastase
(PPE) infusion. Mice were treated with vehicle, 2-ME
(50 mg/kg/day) or digoxin (2 mg/kg/day) starting prior
to, or following, PPE infusion. Therapeutic efﬁcacy was
evaluated using serial aortic diameter ultrasound imaging
and histological analyses at sacriﬁce.
Results: mRNAs for HIF-1a and four genes regulated
by HIF-1a, were up-regulated in aneurysmal aortae. In
vehicle-treated mice, aortic diameters enlarged remarkably
and persistently beginning the third day following PPE
infusion. Pretreatment with either 2-ME, or digoxin,
signiﬁcantly attenuated subsequent PPE-induced aortic
expansion (Fig). Initiated 4 days following PPE infusion,
treatment with both drugs also prevented further enlarge-
ment of existing AAAs. Histologically, treatment with 2-
ME or digoxin was associated with preserved medial
smooth muscle cellularity and elastic ﬁbers, and reduced
mural leukocyte inﬁltration and angiogenesis.
Conclusions: Pharmacological inhibition of HIF-1a
suppresses formation and progression of PPE-induced
AAAs, suggesting the translational potential for HIF-1a
inhibition in human AAA therapy.
